1. Home
  2. ONMD vs BOLD Comparison

ONMD vs BOLD Comparison

Compare ONMD & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONMD
  • BOLD
  • Stock Information
  • Founded
  • ONMD 2006
  • BOLD 2018
  • Country
  • ONMD United States
  • BOLD United States
  • Employees
  • ONMD N/A
  • BOLD N/A
  • Industry
  • ONMD
  • BOLD
  • Sector
  • ONMD
  • BOLD
  • Exchange
  • ONMD Nasdaq
  • BOLD Nasdaq
  • Market Cap
  • ONMD 22.2M
  • BOLD 24.4M
  • IPO Year
  • ONMD N/A
  • BOLD 2024
  • Fundamental
  • Price
  • ONMD $0.85
  • BOLD $1.13
  • Analyst Decision
  • ONMD
  • BOLD Buy
  • Analyst Count
  • ONMD 0
  • BOLD 4
  • Target Price
  • ONMD N/A
  • BOLD $4.00
  • AVG Volume (30 Days)
  • ONMD 19.0M
  • BOLD 72.7K
  • Earning Date
  • ONMD 08-13-2025
  • BOLD 11-06-2025
  • Dividend Yield
  • ONMD N/A
  • BOLD N/A
  • EPS Growth
  • ONMD N/A
  • BOLD N/A
  • EPS
  • ONMD N/A
  • BOLD N/A
  • Revenue
  • ONMD $459,000.00
  • BOLD N/A
  • Revenue This Year
  • ONMD N/A
  • BOLD N/A
  • Revenue Next Year
  • ONMD N/A
  • BOLD N/A
  • P/E Ratio
  • ONMD N/A
  • BOLD N/A
  • Revenue Growth
  • ONMD N/A
  • BOLD N/A
  • 52 Week Low
  • ONMD $0.30
  • BOLD $1.00
  • 52 Week High
  • ONMD $1.56
  • BOLD $4.72
  • Technical
  • Relative Strength Index (RSI)
  • ONMD 58.80
  • BOLD 50.21
  • Support Level
  • ONMD $0.82
  • BOLD $1.10
  • Resistance Level
  • ONMD $0.92
  • BOLD $1.17
  • Average True Range (ATR)
  • ONMD 0.10
  • BOLD 0.04
  • MACD
  • ONMD 0.00
  • BOLD 0.00
  • Stochastic Oscillator
  • ONMD 75.81
  • BOLD 60.00

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its innovative solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. OneMedNet's innovative technology proved the commercial and regulatory viability of imaging Real World Data (as defined below), an emerging market, and provides regulatory-grade image-centric iRWDTM that exactly matches OneMedNet's life science partners' case selection protocols and paves the way for Real World Evidence.

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

Share on Social Networks: